Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone for COVID-19 Patients
November 5, 2021
This initiative will provide the necessary investments to advance first-in-class drug – apabetalone for the potential treatment of COVID-19 within the Arab-African Economy RESVERLOGIX ENTERS INTO A COOPERATION AGREEMENT WITH THE SUPREME COUNCIL OF THE ARAB-AFRICAN ECONOMY TO SUPPORT THE DEVELOPMENT OF APABETALONE FOR COVID-19 PATIENTS From left to right: